Apellis Pharmaceuticals Inc.

26/10/2024 | Press release | Distributed by Public on 27/10/2024 01:11

Pivotal VALIANT Results Presented at Kidney Week Highlight Strength of Pegcetacoplan Treatment Effect in Patients with C3G / Primary IC-MPGN